| Pharmaceutical formulations of hif prolyl hydroxylase inhibitor |
2023-3-27 |
2023-5-16 |
|
| Treatment for congestive heart failure |
2023-1-13 |
2023-7-20 |
|
| Compounds, compositions and methods for histone lysine demethylase inhibition |
2022-8-26 |
2023-3-02 |
|
| Crystalline forms of a prolyl hydroxylase inhibitor |
2022-6-16 |
2022-7-28 |
|
| CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR |
2022-6-15 |
2022-9-09 |
|
| Methods for treatment of motor neuron diseases |
2022-3-07 |
2023-1-19 |
|
| Methods for treating idiopathic pulmonary fibrosis |
2022-1-27 |
2022-5-19 |
|
| Methods of treatment of muscular dystrophies |
2022-1-19 |
2022-5-12 |
|
| Compounds, compositions and methods for histone lysine demethylase inhibition |
2021-8-27 |
2023-3-16 |
|
| Methods for treating anemia in subjects having kidney failure using inhibitors … |
2021-8-05 |
2021-12-02 |
|
| Methods of treating acute respiratory distress syndrome |
2021-3-30 |
2021-9-30 |
|
| Enhanced erythropoiesis and iron metabolism |
2020-12-23 |
2021-4-22 |
|
| Connective tissue growth factor antibodies |
2020-9-08 |
2021-7-29 |
|
| Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
2020-3-13 |
2021-3-04 |
|
| Methods of treating didiopathic pulmonary fibrosis |
2018-9-19 |
2019-5-09 |
|
| Crystalline forms of a prolyl hydroxylase inhibitor |
2018-2-05 |
2019-4-30 |
2019-4-30 |
| Use of HIF alpha stabilizers to increase erythropoiesis. |
2017-9-12 |
2006-1-06 |
|
| 4-hydroxy-isoquinoline compounds as hif-hydroxylase inhibitors |
2017-3-13 |
2017-6-08 |
|
| Crystalline forms of [1-cyano-5-(4-chlorophenoxy)-4-hydroxy- isoquinoline-3- … |
2016-5-11 |
2017-1-06 |
|
| Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) … |
2016-2-12 |
2017-7-04 |
2017-7-04 |
| Cyanoisoquinoline compounds and methods of use thereof |
2015-9-21 |
2016-1-14 |
|
| Treatment for high cholesterol |
2015-6-18 |
2015-12-11 |
|
| Treatment method for lung remodeling diseases |
2015-6-17 |
2015-12-31 |
|
| Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor … |
2015-1-29 |
2015-7-30 |
|
| Therapeutic method for pancreatic cancer |
2015-1-09 |
2015-7-30 |
|
| Thiochromene derivatives as hif hydroxylase inhibitors |
2014-12-24 |
2015-7-02 |
|
| Methods for treatment of muscular dystrophy |
2014-7-01 |
2014-12-04 |
|
| Pharmaceutical formulations of a HIF hydroxylase inhibitor |
2014-6-05 |
2021-9-28 |
|
| TABLET AND CAPSULE COMPRISING [(4-HYDROXY-1-METHYL-7-PHENOXY-ISOQUINOLINE-3- … |
2014-6-05 |
2023-7-18 |
|
| Pharmaceutical formulations of a hif hydroxylase inhibitor |
2014-6-05 |
2021-9-28 |
|
| Novel thienopyridine compounds, and methods of use thereof |
2014-4-09 |
2014-8-07 |
|
| Connective Tissue Growth Factor Antisense Oligonucleotides |
2014-3-07 |
2014-7-03 |
|
| CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE |
2014-2-24 |
2015-9-02 |
|
| CRYSTAL FORMS OF AN INHIBITOR OF THE PROLIL HYDROXYLASE |
2014-2-24 |
2014-8-29 |
|
| Methods For Reducing Blood Pressure |
2014-2-14 |
2014-6-12 |
|
| Compound and method for cancer treatment |
2013-8-15 |
2014-1-23 |
|
| METHODS FOR THE PRODUCTION OF ISOQUINOLINE COMPOUNDS |
2013-7-15 |
2021-11-09 |
|
| Therapeutic methods for peritoneal carcinomatosis |
2013-3-12 |
2013-10-03 |
|
| Compositions and Methods for Treating Brain Tumors |
2012-11-08 |
2014-3-06 |
|
| Therapeutic method |
2012-11-08 |
2013-5-16 |
|
| Treatments for cancer |
2012-9-12 |
2014-5-20 |
2014-5-20 |
| Methods for treating anemia |
2012-8-16 |
2015-5-07 |
|
| Compound that inhibits hif prolyl hydroxylase activity for use in decreasing … |
2012-3-28 |
2016-3-31 |
|
| Therapeutic method using anti - ctgf antibody |
2012-1-23 |
2012-7-26 |
|
| Methods for increasing mean corpuscular volume |
2012-1-13 |
2012-7-19 |
|
| Methods for increasing reticulocyte hemoglobin content |
2012-1-13 |
2012-7-19 |
|
| Vascular Disease Therapies |
2011-10-21 |
2012-2-16 |
|
| Compounds and methods for treatment of stroke |
2011-7-11 |
2017-10-03 |
2017-10-03 |
| Isoxazolopyridine derivatives for use in the treatment of hif-mediated … |
2011-3-11 |
2011-9-02 |
|
| Method for producing double-crosslinked collagen |
2011-2-20 |
2011-4-28 |
|
| Pyrrolo [1,2-b] pyridazine derivatives and their use as hif modulators |
2011-2-20 |
2011-4-28 |
|
| Treatment for Radiation-Induced Disorders |
2010-11-08 |
2012-9-27 |
|
| Treatment method for anemia |
2010-8-26 |
2010-12-30 |
|
| Compounds and methods for treatment of cancer-related anemia |
2010-8-16 |
2011-1-20 |
|
| Compound and method for treatment of chronic transplant rejection |
2010-6-17 |
2011-5-12 |
|
| Diabetic nephropathy therapies |
2010-6-03 |
2012-11-20 |
2012-11-20 |
| Compounds and methods for treatment of chemotherapy-induced anemia |
2010-4-13 |
2010-8-12 |
|
| Fat regulation |
2009-10-19 |
2012-6-19 |
2012-6-19 |
| Methods for treatment of focal segmental glomerulosclerosis |
2009-10-07 |
2010-4-15 |
|
| Methods for treatment of podocyte injury |
2009-10-07 |
2010-4-15 |
|
| Methods for treatment of multiple sclerosis |
2009-8-26 |
2010-3-04 |
|
| Methods for increasing neurogenesis |
2009-8-26 |
2010-3-04 |
|
| Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
2009-7-14 |
2009-10-02 |
|
| Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors |
2009-2-05 |
2012-12-04 |
2012-12-04 |
| Methods for reducing blood pressure |
2009-1-08 |
2009-4-17 |
|
| Methods for inhibiting t helper cell differentiation |
2008-12-08 |
2010-6-10 |
|
| Methods for inhibiting t helper cell differentiation |
2008-12-08 |
2009-6-18 |
|
| Methods for increasing white blood cells |
2008-12-08 |
2009-6-18 |
|
| Methods for increasing endothelial progentior cells |
2008-12-08 |
2010-9-29 |
|
| Stabilization of hypoxia inducible factor (HIF) alpha |
2008-3-05 |
2008-4-03 |
|
| Diagnostic marker for diabetic vascular complications |
2007-11-27 |
2008-1-30 |
|
| Hif prolyl hydroxylase activity assay |
2007-9-20 |
2007-11-09 |
|
| Implantable collagen compositions |
2007-5-09 |
2010-12-30 |
|
| Electron emission display |
2006-10-24 |
2007-6-28 |
|
| Methods of assaying connective tissue growth factor |
2006-9-22 |
2007-1-25 |
|
| Ctgf as target for the therapy of diabetic nephropathy |
2006-8-11 |
2007-4-10 |
|
| Methods for improving kidney function |
2006-6-01 |
2012-11-27 |
2012-11-27 |
| Cardiovascular disease therapies |
2006-5-05 |
2008-7-02 |
|
| Roxadustat |
2022-6-15 |
2022-6-15 |
|
| Comprimido e cápsula compreendendo ácido [(4-hidróxi-1-metil-7-fenóxi- … |
2014-6-05 |
2023-7-18 |
|
| Métodos para a produção de compostos de isoquinolina |
2013-7-15 |
2021-11-09 |
|
| Ctgf como objetivo para la terapia de nefropatia diabetica |
2006-8-11 |
2007-4-10 |
|